Tosk Stock
Tosk is a biopharmaceutical company dedicated to improving the safety of drugs for diseases such as cancer, arthritis, and psoriasis.
Sign up today and learn more about Tosk Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Tosk Stock
Tosk Incorporated is a biopharmaceutical company dedicated to improving the safety and efficacy of drugs for debilitating and life-threatening diseases such as cancer, arthritis, and psoriasis. Side effects limit the use and effectiveness of many of today's pharmaceutical products. Tosk employs proprietary methods to discover and develop new drugs that reduce or eliminate the adverse effects of existing pharmaceuticals while maintaining their efficacy. This approach not only improves upon proven treatment regimens, but also has the potential to deliver these enhanced drugs to the medical community more quickly and with lower research and development costs than is typically required for an entirely new drug.
Funding History
July 2014 | $5.4M |
---|
Management
PhD, Vice President, R&D
William A. Garland
President and CEO
Brian Frenzel
Director
Charles Garvin
Chairman of the Board
Harold Crow
VP Research
Stephen Yanofsky
Press
sec - Feb, 5 2021
Form D